Journal profile
Oncobiology and Targets
ISSN 2395-4469 · HATASO · United States
Oncobiology and Targets: fully open access; review about 8 weeks (community reports); 0 articles in 2025.
Scope
Aims, scope and focus
Oncobiology and Targets is published by HATASO. By OpenAlex counts of its recent articles, its largest topics are Oral Health Pathology and Treatment, Head and Neck Cancer Studies and Cancer Cells and Metastasis, together about 26.1% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Main research topics OpenAlex counts of recent articles; shares are approximate
- Oral Health Pathology and TreatmentDentistry13%
- Head and Neck Cancer StudiesMedicine6.5%
- Cancer Cells and MetastasisMedicine6.5%
- Oral health in cancer treatmentMedicine6.5%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.4%
- Sarcoma Diagnosis and TreatmentMedicine4.4%
- Prostate Cancer Treatment and ResearchMedicine4.4%
- Viral-associated cancers and disordersMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 4OpenAlex ·
- i10-index
- 1OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 26 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 4 |
| 2025 | 0 | 0 | 1 |
| 2024 | 0 | 0 | 8 |
| 2023 | 0 | 0 | 3 |
| 2022 | 0 | 0 | 7 |
| 2021 | 0 | 0 | 4 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 8 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- HATASO
- Country or region
- United States
- Language
- English
- ISSN
- 2395-4469
- Official links
- Journal homepage ↗LetPub
FAQ
Frequently asked questions about Oncobiology and Targets
How long does peer review take at Oncobiology and Targets?
Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is Oncobiology and Targets open access, and what is the APC?
Oncobiology and Targets is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .